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Collegiality without borders
I write 2 days after returning from an international 
conference on publication ethics. The participants 
were highly knowledgeable and engaged; many were 
both editors-in-chief and practising consultants. 
We discussed the perennial issues of authorship and 
conﬂ icts of interest, as well as newer and more bizarre 
transgressions such as journal hijacking and reviewer 
impersonation. Time outside the meeting room was 
spent networking and socialising with international 
colleagues over food and drink, and on organised tours 
of the city and its ample supply of cultural and historical 
points of interest. Not so unusual, perhaps, except that 
the city was Shiraz and the country Iran.
Strip away the current political tensions over nuclear 
proliferation, and Iran’s rich history of progressive 
medical and scientiﬁ c research shines through. In 
Zoroastrian Persia, before the arrival of Islam in the 
7th Century, the practice of medicine—“by the knife, 
by herbs, and by divine words”—was described in 
the religious text the Avesta. Later, Persian scholars 
contributed to the huge advances made in scientiﬁ c 
analysis and evidence-based medicine during 
the Islamic Golden Age. Nowadays, 38% of the 
42 500 masters and doctoral students Iran produces 
every year are studying science or technology—a 
proportion comparable with Japan. Unlike other Islamic 
nations in the region, there are as many women as 
men in higher education. Compound annual growth 
in scientiﬁ c publication output exceeds 25%, and more 
than 300 medical journals are published in the country, 
nearly all by universities.
This long-standing national commitment to the 
practice and teaching of science and medicine ought to 
place Iran in the top echelons of international scientiﬁ c 
collaboration. But of course it does not. Poor diplomatic 
relations and sanctions imposed chieﬂ y by the USA and 
EU make travel diﬃ  cult (Iranian visas to UK citizens are 
currently issued by Iran’s Embassy in Dublin, Ireland, 
for example) and the transfer of money (eg, research 
funding) between Iran and sanction-imposing countries 
is virtually impossible. The ban on ﬁ nancial transactions 
also aﬀ ects subscription payments to US or EU-based 
journals and article processing charges for open access 
journals. Additionally, some publishers have instructed 
their US employees not to handle submissions from 
authors employed by the Iranian government (most 
universities are technically government entities). Thus 
both access to research and the ability to publish are 
restricted for Iranian researchers.
And the damage does not stop at collaborative 
barriers and publishing embargoes. Although 
medicines and medical devices are exempt from 
the US and EU export ban, restrictions on ﬁ nancial 
transactions render the exemption moot in practice. 
The result is drug shortages, price increases, and the 
rise of substandard black-market products. Observers 
have urged Washington and Brussels to make clear to 
ﬁ nancial institutions that trade in necessary medical 
products is legal.
Facilitation of a ﬁ nancial channel to support 
humanitarian trade was in fact one of the concessions 
agreed in the Joint Plan of Action drawn up between 
Iran and the so-called P5+1 nations (the USA, UK, 
France, Russia, China, and Germany) in January 2014. 
The Plan oﬀ ers a slight relaxation of sanctions in 
return for Iran’s limiting uranium enrichment and 
allowing inspectors into nuclear facilities. According 
to the Arms Control Association, both sides have 
stuck to their commitments so far, but the deal is 
only temporary and negotiations on reaching a ﬁ nal 
agreement have just been extended for the second 
time until July 2015.
At times frustrations ran high in Shiraz, but they 
did not deﬂ ect from the prevailing atmosphere of 
mutual respect between fellow academics and editors. 
Economic sanctions are sometimes a necessary evil, 
but the consequences of blanket policies can be far-
reaching and damage aspects of life—health care, 
access to health information, bioscientiﬁ c progress—
that ought to be unassailable. As researchers and 
editors, we can have little hope of inﬂ uencing high-
level foreign policy. But what we can do is ensure that 
we do not slip into the trap of judging our international 
peers by the actions of their governments. We can 
extend the hand of fellowship and collegiality because 
we feel it to be right even if the letter of the law says 
that it is not. 
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For data on trends in current 
scientiﬁ c research in Iran see 
http://www.uis.unesco.org/
Library/Documents/higher-
education-asia-graduate-
university-research-2014-en.pdf
For more on publishers and 
manuscripts from Iranian 
authors see Lancet 2013; 
382: 596
For more on sanctions and 
medical supply shortages in 
Iran see World Report Lancet 
2013; 381: 279 and http://www.
wilsoncenter.org/sites/default/
ﬁ les/sanctions_medical_supply_
shortages_in_iran.pdf
For the Arms Control 
Association report on 
implementation of the Joint 
Plan of Action see http://www.
armscontrol.org/
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